MENLO PARK, Calif.--Akoya Biosciences, Inc., today announced the appointment of Joseph Driscoll as Chief Financial Officer. Mr. Driscoll joins Akoya with more than 30 years of financial leadership experience and a proven track record of driving growth and increasing company valuations. “I am delight [...]
Austin, Texas — 04/02/2019 — Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy-to-use products for complex testing in genetics and oncology, today announced a substantial update to its AmplideX Reporter software for the automated downstream data analysis of assays in the [...]
The Horizon ® system was designed to offer more versatility in one system, and more treatment options for patients. This clearance allows Magstim to market the 3-minute iTBS protocol. Clinicians have options to deliver treatments with the standard repetitive Transcranial Magnetic Stimulation (rTMS [...]
Seattle, WA, March 28, 2019 – RareCyte® announces the CyteFinder® II and CyteFinder II HT Instruments in conjunction with the American Association for Cancer Research Annual Meeting in Atlanta, March 29 through April 3. These next generation CyteFinder Instruments expand on RareCyte’s world class li [...]
March 20, 2019 – Guilford, CT/Walnut Creek, CA – Medpricer, the leading purchased services cost management solution for the healthcare industry, announced today the launch of its mSource®Predictive Plan, a new analytics feature that redefines strategic planning for purchased services by giving custo [...]
Cardiff, UK, and Baltimore, U.S., January 29, 2018 – TrakCel, the software developer for cell and gene therapy supply chain tracking and orchestration systems, and WindMIL Therapeutics, a clinical stage oncology cell therapy company leveraging a proprietary platform to develop a novel class of cell [...]
